Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |